Tallenna
Interferon Alpha-2: Pre-Clinical and Clinical Evaluation
Interferon alpha-2 is a genetically engineered, highly purified pharmaceutical agent that has undergone extensive phase I and phase II clinical study in more than 1000 patients.
- Alaotsikko
- Proceedings of the Symposium held in Adjunction with the Second International Conference on Malignant Lymphoma, Lugano, Switzerland, June 13, 1984
- Toimittaja
- Daniel L. Kisner, J.F. Smyth
- Painos
- Softcover reprint of the original 1st ed. 1985
- ISBN
- 9781461296188
- Kieli
- englanti
- Paino
- 310 grammaa
- Julkaisupäivä
- 5.10.2011
- Kustantaja
- Springer-Verlag New York Inc.
- Sivumäärä
- 112
